cholecystokinin (27-33) has been researched along with ci 988 in 1 studies
| Studies (cholecystokinin (27-33)) | Trials (cholecystokinin (27-33)) | Recent Studies (post-2010) (cholecystokinin (27-33)) | Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) |
|---|---|---|---|---|---|
| 39 | 0 | 0 | 147 | 8 | 14 |
| Protein | Taxonomy | cholecystokinin (27-33) (IC50) | ci 988 (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 2.8672 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.03 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 1.0471 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwell, DC | 1 |
1 other study(ies) available for cholecystokinin (27-33) and ci 988
| Article | Year |
|---|---|
Development of CCK-B antagonists.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood-Brain Barrier; Cerebral Cortex; Cholecystokinin; Drug Design; Indoles; Meglumine; Mice; Molecular Sequence Data; Peptide Fragments; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship | 1991 |